← SynDRA
MIRABEGRON
SynDRA canonical compound SYN0029964 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ADRB1 | ADRB2 | ADRB3 |
|---|
| Mechanism of action | adrenergic receptor agonist |
|---|
| Indication | urinary incontinence |
|---|
| Disease area | urology |
|---|
All known targets
Mechanisms of action (all sources)
- ADRB3 AGONIST
- Beta-3 adrenergic receptor agonist
- adrenergic receptor agonist
- ADRB3 MODULATOR
Drug classes
- Adrenergic Agents
- Adrenergic Agonists
- Adrenergic beta-3 Receptor Agonists
- Adrenergic beta-Agonists
- Neurotransmitter Agents
- Urological Agents
- Cytochrome P450 2D6 Inhibitors
- Adrenergic beta3-Agonists
- beta3-Adrenergic Agonist
- P-Glycoprotein Inhibitors
- Cytochrome P450 3A Inhibitors
ATC classes
Cross-references
Synonyms
- YM178
- myrbetriq
- Betanis
- YM-178
- Betmiga
- Myrbetriq
- Myrbetriq granules
- Myrbetriq (TN)
- MVR3JL3B2V
- YM 178
- CHEBI:65349
- mirabegronum
- RefChem:58592
- MYRBETRIQ GRANULES
- G04BD12
- DTXCID401506657
- Mirabegron (YM178)
- MFCD11100356
- C21H24N4O2S
- Mirabegron [USAN:INN]
- UNII-MVR3JL3B2V
- Mirabegron CRS
- Mirabegron (Standard)
- Mirabegron racemate CRS
- MIRABEGRON [MI]
- MIRABEGRON [INN]
- MIRABEGRON [JAN]
- MIRABEGRON [USAN]
- Mirabegron [EP monograph]
- MIRABEGRON [VANDF]
- MIRABEGRON [MART.]
- MIRABEGRON [WHO-DD]
- Mirabegron (JAN/USAN/INN)
- SCHEMBL904788
- GTPL7445
- orb1307816
- MIRABEGRON [ORANGE BOOK]
- GLXC-10840
Look up MIRABEGRON in the interactive SynDRA portal →